Exane Derivatives’s Walgreens Boots Alliance WBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-4,123
Closed -$225K 704
2019
Q2
$225K Buy
+4,123
New +$219K 0.04% 250
2018
Q4
Sell
-1
Closed -$73 746
2018
Q3
$73 Hold
1
﹤0.01% 633
2018
Q2
$59 Hold
1
﹤0.01% 633
2018
Q1
$66 Sell
1
-20
-95% -$1.43K ﹤0.01% 565
2017
Q4
$1.52K Sell
21
-2
-9% -$141 ﹤0.01% 474
2017
Q3
$1.78K Hold
23
﹤0.01% 445
2017
Q2
$1.8K Sell
23
-14
-38% -$1.15K ﹤0.01% 452
2017
Q1
$3.07K Sell
37
-720
-95% -$60.4K ﹤0.01% 387
2016
Q4
$62.6K Sell
757
-1,127
-60% -$93.2K 0.01% 280
2016
Q3
$152K Buy
1,884
+679
+56% +$55.4K 0.02% 215
2016
Q2
$100K Sell
1,205
-866
-42% -$69.9K 0.02% 242
2016
Q1
$174K Sell
2,071
-1,163
-36% -$92.9K 0.02% 203
2015
Q4
$275K Sell
3,234
-564
-15% -$47.9K 0.04% 147
2015
Q3
$316K Sell
3,798
-716
-16% -$64.7K 0.04% 154
2015
Q2
$381K Buy
4,514
+2,224
+97% +$192K 0.04% 160
2015
Q1
$194K Buy
+2,290
New +$182K 0.02% 208

Other funds holding WBA

Exane Derivatives's WBA Position: Q3 2019 in Review

Exane Derivatives sold out of Walgreens Boots Alliance (WBA) in Q3 2019, closing a stake of 4,123 shares — an estimated $225K sold.

Exane Derivatives first reported a position in WBA in Q1 2015 and held it in 16 quarters. The position peaked at $381K in Q2 2015. 1,258 funds tracked by Wall St. Rank hold WBA as of Q3 2019.

  • Exane Derivatives reported no remaining Walgreens Boots Alliance position as of Q3 2019 after selling out during the quarter.
  • Exane Derivatives sold 4,123 Walgreens Boots Alliance shares in Q3 2019, an estimated $225K.
  • Exane Derivatives first reported a position in Walgreens Boots Alliance in Q1 2015 and held it in 16 quarters.
  • Exane Derivatives's Walgreens Boots Alliance position peaked at $381K in Q2 2015.
  • 1,258 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q3 2019.

Based on Exane Derivatives's 13F filing for Q3 2019, filed 15 Oct 2019.